Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pd-1 Inhibitors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT04411706
What this trial is testing

Sintilimab Combined With Apatinib and Capecitabine in Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Xin-Hua Xu 46
Testing effectiveness (Phase 2)Study completedNCT04767906
What this trial is testing

Cabozantinib Treatment in a Phase II Study for Patients With Hepatocellular Carcinoma (HCC) Refractory to PD-1 Inhibitors

Who this might be right for
Hepatocellular Carcinoma
University of Leipzig 16
Testing effectiveness (Phase 2)Study completedNCT03463876
What this trial is testing

A Trial of SHR-1210 (an Anti-PD-1 Inhibitor) in Combination With Apatinib in Patients With Advanced HCC(RESCUE)

Who this might be right for
Hepatocellular Carcinoma
Jiangsu HengRui Medicine Co., Ltd. 190
Early research (Phase 1)Looking for participantsNCT07565740
What this trial is testing

Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC

Who this might be right for
HPV-positive Oropharyngeal Squamous Cell Carcinoma
West China Hospital 9
Large-scale testing (Phase 3)Active Not RecruitingNCT07541755
What this trial is testing

PD-1 Inhibitors +Venetoclax+CAG Regimens in R/R T-ALL

Who this might be right for
Acute T Lymphoblastic Leukemia (T-ALL)
Fujian Medical University Union Hospital 40
Early research (Phase 1)Study completedNCT02574533
What this trial is testing

Pilot Study of Vigil™ + Pembrolizumab for Advanced Melanoma

Who this might be right for
Melanoma RecurrentMalignant MelanomaMelanoma
Gradalis, Inc. 2
Not applicableUnknownNCT04722406
What this trial is testing

Tumor Growth Rate (TGR) Predicts Clinical Outcomes for Advanced Non-small Cell Lung Cancer Undergoing Immunotherapy.

Who this might be right for
Non-Small Cell Lung Cancer
Sun Yat-sen University 350
Testing effectiveness (Phase 2)Looking for participantsNCT07332247
What this trial is testing

PD-1 Inhibitor Plus Chemotherapy Followed by Immediate Versus Selective Re-irradiation for Locally Advanced Recurrent NPC

Who this might be right for
Nasopharangeal CancerRecurrent Nasopharynx Carcinoma
Sun Yat-sen University 94
Testing effectiveness (Phase 2)Looking for participantsNCT06811844
What this trial is testing

Two-cycle and Three-cycle Induction Therapy With Modified TPF Regimen Combined and Camrelizumab for LANPC

Who this might be right for
Nasopharyngeal NeoplasmsPD-1 InhibitorInduction Therapy+2 more
The First Affiliated Hospital of Xiamen University 208
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07090707
What this trial is testing

PD-1 Inhibitor Therapy Versus Radiotherapy in MPR Patients With Locally Advanced HNSCC After Neoadjuvant Immunochemotherapy (HNC-SYSU-006)

Who this might be right for
HNSCCPD-1Radiotherapy
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 50
Testing effectiveness (Phase 2)UnknownNCT03987698
What this trial is testing

Study of PD-1 Inhibitor Combination With Autologous Cell Immunotherapy in the Metastatic Renal Cell Carcinoma

Who this might be right for
Renal Cell CarcinomaClear Cell Renal Cell Carcinoma
Tianjin Medical University Cancer Institute and Hospital 90
Testing effectiveness (Phase 2)UnknownNCT03601598
What this trial is testing

A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC

Who this might be right for
CRCHCCNSCLC
Harbin Medical University 41
Not applicableLooking for participantsNCT07272382
What this trial is testing

Omega-3 Fatty Acids With PD-1 Inhibitors in Advanced Esophageal Cancer

Who this might be right for
Esophageal Neoplasms
Fudan University 142
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07159217
What this trial is testing

Disitamab Vedotin Plus Lenvatinib and PD-1 Inhibitors for Treating HER2-positive Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract CancerDisitamab VedotinLenvatinib+1 more
Peking Union Medical College Hospital 65
Not applicableLooking for participantsNCT07041320
What this trial is testing

Oral Metronomic Vinorelbine and PD-1 Inhibitors in Elderly Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer (NSCLC)Elderly (People Aged 65 or More)
Anhui Chest Hospital 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07543848
What this trial is testing

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

Who this might be right for
Rectal NeoplasmsRectal Adenocarcinoma
Chongqing University Cancer Hospital 20
Not applicableLooking for participantsNCT07697859
What this trial is testing

PD-1 Inhibitors Combined With Local Therapy at Different Timings in Oligometastatic ESCC

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)
Fudan University 354
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07602140
What this trial is testing

TACE Combined With Thermal Ablation and ADC, PD-1, and Chemotherapy as First-line Treatment for HER2-highly-expressing Gastric Cancer With Liver Metastases: A Multicenter, Single-arm Prospective Clinical Study.

Who this might be right for
Gastric Cancer With Liver Metastases
Shandong Provincial Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT07263386
What this trial is testing

A Phase II, Multicenter, Randomized, Controlled Clinical Study Comparing the Efficacy and Safety of Sintilimab Plus SOX Versus SOX Alone as Adjuvant Therapy for PD-L1-Positive, Stage pN3 Gastric Cancer

Who this might be right for
Gastric Adenocarcinoma
The First Affiliated Hospital with Nanjing Medical University 460
Not applicableUnknownNCT04268368
What this trial is testing

Immune Related-adverse Events in Patients Receiving Immune Checkpoint Inhibitors

Who this might be right for
CancerLung CancerRenal Cell Carcinoma+1 more
Università Politecnica delle Marche 200
Next Page